Показано 0 из 0
Дата |
---|
02.07.2024 |
01.07.2024 |
28.06.2024 |
27.06.2024 |
26.06.2024 |
25.06.2024 |
24.06.2024 |
21.06.2024 |
20.06.2024 |
18.06.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
3.55
|
4.20
|
3.70
|
3.52
|
3.71
|
3.53
|
|
|
27 865.13
|
146.00
|
3.48
|
4.14
|
3.65
|
3.495
|
3.65
|
3.6123
|
|
|
108 583.34
|
282.00
|
3.66
|
4.22
|
3.63
|
3.5001
|
3.76
|
3.76
|
|
|
136 205.15
|
401.00
|
3.60
|
4.48
|
3.68
|
3.51
|
3.75
|
3.62
|
|
|
95 810.52
|
386.00
|
3.58
|
3.69
|
3.475
|
3.4101
|
3.74
|
3.74
|
|
|
164 337.85
|
367.00
|
3.33
|
4.00
|
3.81
|
3.55
|
3.8699
|
3.55
|
|
|
79 666.99
|
308.00
|
3.75
|
3.87
|
4.08
|
3.7525
|
4.2499
|
3.78
|
|
|
341 708.64
|
749.00
|
4.15
|
4.45
|
4.8301
|
4.02
|
4.84
|
4.02
|
|
|
299 667.50
|
619.00
|
4.81
|
5.00
|
5.03
|
4.81
|
5.293
|
4.83
|
|
|
108 611.69
|
309.00
|
5.02
|
5.14
|
5.02
|
5.01
|
5.26
|
5.05
|
|
|
158 754.74
|
446.00
|
ZyVersa is a clinical stage specialty biopharmaceutical company leveraging advanced proprietary technologies to develop first-in-class drugs for patients with inflammatory or kidney diseases with high unmet medical needs.